When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
Novo Nordisk ( (NVO) ) has provided an announcement.
New studies link diabetes drug Ozempic to increased risk of NAION, a rare eye condition causing vision loss. Danish Medicines ...
The European Union's drug regulator said it would review a potential link between Novo Nordisk's blockbuster diabetes drug, Ozempic, and a rare eye condition that causes vision loss after recent ...
Novo Nordisk plans to buy from the holding company three sites — Brussels; Anagni, Italy; and Bloomington — for $11.7 billion ...
1d
Hosted on MSNNovo Nordisk invests $1.2bn in new Denmark facilityConstruction has already begun on the Ozempic-producer’s new Danish production facility and 40,000m² warehouse.
Denmark's drug regulator asks EMA to investigate potential link between Novo Nordisk's diabetes drug Ozempic and rare eye ...
It’s not a new question, but it is one that is gaining increased traction: Is there a link between Novo Nordisk’s diabetes ...
A vision-threatening eye condition may be linked to Ozempic. Meanwhile, Nearly 80% of doctors are using telemedicine weekly, ...
Denmark's state-of-the-art AI supercomputer, Gefion, has achieved another global recognition by ranking 7th overall and 4th in the 10-node benchmark on the internationally recognised IO500 list.
Current health news briefs cover potential risks linked to Novo Nordisk's diabetes drug Ozempic, opposition to Robert F.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results